Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Alterity Therapeutics Ltd
ATHECurrent price
4.2 USD
-0.05 USD (-1.18%)
Last closed
0.004 AUD
Company
alteritytherapeutics.com
Sector
Healthcare
Industry
Biotechnology
Exchange
AU
Capitalization
9 902 962 AUD
Yield for 12 month
-60.00 %
Week
Month
Year
ATHE
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Address: American Century Mutual Funds, Inc.
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+3 973 865 AUD
Last Year
+2 537 AUD
Current Quarter
+776 489 AUD
Last Quarter
+776 489 AUD
Current Year
+3 684 611 AUD
Last Year
–
Current Quarter
+713 054 AUD
Last Quarter
+713 054 AUD
Key Figures ATHE
1 year
3 years
5 years
10 years
EBITDA
-14 812 743 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.64 %
PEG Ratio
–
Return On Equity TTM
-47.38 %
Wall Street Target Price
–
Revenue TTM
3 973 866 AUD
Book Value
0.0091 AUD
Revenue Per Share TTM
0.002 AUD
Dividend Share
–
Quarterly Revenue Growth YOY
-44.6 %
Dividend Yield
–
Gross Profit TTM
3 684 611 AUD
Earnings Share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATHE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ATHE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
5.02 %
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ATHE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
164.749
Price Sales TTM
4.2279
Enterprise Value EBITDA
0.7041
Price Book MRQ
0.6786
Financials ATHE
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ATHE
For 52 weeks
0.003 AUD
0.011 AUD
50 Day MA
0.0068 AUD
Shares Short Prior Month
–
200 Day MA
0.0072 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
Google
Apple
Facebook